Pluri Inc. (PLUR) États Financiers et Données Historiques

Pluri Inc. (PLUR) — Prix $1.14 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Pluri Inc. (PLUR): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Marges des 12 derniers mois: marge brute 19.0%, marge opérationnelle -24.1%, marge nette -24.2%.

Au prix actuel de $1.14, PLUR affiche des résultats négatifs (PER non significatif) et un ROE de 203.55%. La capitalisation boursière s'établit à $12M.

Compte de Résultat (10 ans)

Année2017201820192020202120222023202420252026
Revenus0$50000$54000$230000$234000$287000$326000$1.3M$1.0M
Coût des Ventes$2.2M$2000$2000$1.6M$1.4M$1.1M$9000$4000$682000$563000
Marge Brute-$2.2M$48000$52000-$1.5M-$1.4M-$819000$278000$322000$654000$453000
R&D$21.1M$22.6M$24.6M$20.1M$30.1M$24.4M$15.7M$12.4M$12.9M$15.3M
Frais Généraux$6.9M$11.2M$9.2M$7.8M$20.6M$17.4M$11.8M$10.0M$10.0M$10.3M
Charges Opérationnelles$28.0M$33.8M$35.6M$27.9M$49.3M$40.8M$27.5M$22.5M$22.8M$25.4M
Résultat Opérationnel-$28.0M-$33.7M-$35.5M-$29.5M-$50.6M-$41.6M-$27.2M-$22.2M-$22.2M-$24.9M
EBITDA-$25.6M-$24.1M-$33.3M-$27.4M-$48.4M-$39.4M-$27.7M-$20.2M-$22.1M-$24.4M
Charges d'Intérêt0$937000$29000$196000$78000$887000$843000$866000$873000-$932000
Résultat Avant Impôts-$27.8M-$26.1M-$35.3M-$29.2M-$49.9M-$41.4M-$28.9M-$21.3M-$23.3M-$25.4M
Impôts-$2050000-$9400000000-$5000-$25000
Résultat Net-$27.8M-$26.1M-$35.3M-$29.2M-$49.9M-$41.2M-$28.3M-$20.9M-$22.6M-$23.8M
BPA$-25.45$-19.74$-23.20$-12.80$-14.19$-10.24$-6.18$-3.99$-3.56$-2.44
BPA Dilué$-25.45$-19.74$-23.20$-12.80$-14.19$-10.24$-6.18$-3.99$-3.56$-2.44
Actions en Circulation (Diluées)$1.1M$1.3M$1.5M$2.3M$3.5M$4.0M$4.6M$5.2M$6.3M$9.7M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$316000$198000$167000$335000
Marge Brute-$15000-$43000$56000$455000
Résultat Opérationnel-$6.3M-$6.5M-$6.5M-$5.5M
EBITDA-$5.8M-$6.5M-$6.3M-$5.4M
Résultat Net-$5.8M-$6.5M-$6.2M-$5.9M
BPA$-0.65$-0.71$-0.55$-0.54
BPA Dilué$-0.65$-0.71$-0.55$-0.54

Bilan (10 ans)

Année2017201820192020202120222023202420252026
Trésorerie$4.7M$8.8M$4.1M$8.8M$31.2M$9.8M$5.4M$6.8M$5.9M$3.5M
Placements à Court Terme$21.4M$21.1M$19.6M$37.5M$33.7M$45.2M$34.8M$23.2M$14.7M$4.3M
Créances$1.2M$847000$1.4M$1.6M$1.5M$1.3M$527000$638000$722000$219000
Stocks00$6920000000000
Actifs Courants$29.0M$32.0M$26.4M$48.5M$67.4M$57.7M$41.4M$31.1M$22.1M$8.7M
Immobilisations Corporelles$7.3M$5.7M$3.8M$3.8M$2.2M$9.0M$8.3M$7.2M$8.7M$7.7M
Goodwill00000000$3.1M$3.1M
Actifs Incorporels00000000$2.8M$2.6M
Actifs Totaux$37.5M$39.0M$31.3M$65.5M$93.5M$68.1M$50.8M$39.5M$38.7M$24.9M
Dettes Fournisseurs$2.0M$3.3M$2.3M$2.0M$2.5M$1.8M$1.8M$964000$866000$702000
Dette à Court Terme000$1.0M0000$27.3M$27.4M
Passifs Courants$5.4M$8.5M$8.2M$8.0M$11.5M$6.8M$5.6M$4.5M$32.3M$32.7M
Dette à Long Terme0000$23.9M$21.7M$23.5M$24.0M00
Passifs Totaux$7.3M$10.5M$9.5M$9.4M$36.4M$35.9M$35.5M$34.1M$39.5M$42.3M
Réserves-$189.6M-$215.7M-$251.0M-$280.2M-$330.0M-$371.3M-$399.6M-$420.5M-$443.1M-$466.9M
Capitaux Propres$30.3M$28.5M$21.8M$56.1M$57.2M$30.0M$13.4M$96000-$6.8M-$23.0M
Dette Totale000$1.6M$24.6M$28.8M$29.9M$29.6M$34.0M$34.9M
Dette Nette-$26.1M-$29.9M-$23.7M-$44.8M-$40.4M-$26.2M-$10.3M-$373000$13.4M$27.1M
Fonds de Roulement$23.6M$23.5M$18.2M$40.5M$55.9M$50.9M$35.8M$26.7M-$10.2M-$24.0M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$4.7M$4.9M$3.6M$3.5M
Actifs Totaux$33.7M$30.6M$26.1M$24.9M
Passifs Totaux$39.3M$39.8M$39.1M$42.3M
Capitaux Propres-$11.4M-$14.6M-$18.6M-$23.0M
Dette Totale$40.3M$40.8M$33.6M$34.9M

Tableau de Flux (10 ans)

Année2017201820192020202120222023202420252026
Résultat Net-$27.8M-$26.1M-$35.3M-$29.2M-$49.9M-$41.4M-$28.9M-$21.3M-$23.2M-$25.4M
Amortissements$2.2M$2.0M$2.0M$1.6M$1.4M$1.1M$362000$253000$316000$511000
Stock-based Compensation$3.7M$6.5M$5.1M$2.6M$14.0M$8.9M$4.0M$2.6M$2.1M$3.7M
Variation du BFR-$134000$3.7M-$1.3M-$1.3M$3.5M-$5.1M$1.7M-$21000$4.2M$1.6M
Cash Flow Opérationnel-$21.6M-$21.4M-$29.5M-$26.4M-$30.9M-$36.5M-$22.9M-$18.0M-$18.2M-$19.6M
CapEx-$378000-$342000-$239000-$270000-$373000-$280000-$262000-$323000-$1.6M-$633000
Acquisitions$30000-$1.9M$600000000$373000$18000
Rachat d'Actions0000000000
Dividendes Payés0000000000
Free Cash Flow-$22.0M-$21.7M-$29.7M-$26.6M-$31.3M-$36.8M-$23.1M-$18.3M-$19.8M-$20.2M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$5.4M-$5.2M-$4.5M-$4.4M
CapEx-$116000-$447000-$44000-$26000
Free Cash Flow-$5.5M-$5.7M-$4.6M-$4.5M
Dividendes Payés0000
Stock-based Compensation$1.4M$763000$1.1M$476000

Croissance et Marges (10 ans)

Année2017201820192020202120222023202420252026
Croissance Revenus (annuelle)+8.0%-57.4%-100.0%+22.6%+13.6%+309.8%-24.0%
Croissance Résultat Net (annuelle)+6.1%-35.1%+17.4%-71.1%+17.3%+31.3%+26.2%-8.1%-5.5%
Croissance BPA (annuelle)+22.4%-17.5%+44.8%-10.9%+27.8%+39.6%+35.4%+10.8%+31.5%
Variation Actions (annuelle)+21.0%+16.6%+47.5%+54.5%+14.5%+13.9%+14.4%+20.9%+53.8%
Croissance FCF (annuelle)+1.2%-36.7%+10.3%-17.4%-17.6%+37.1%+20.7%-8.1%-2.0%
Marge Brute96.0%96.3%-6726.1%-350.0%96.9%98.8%49.0%44.6%
Marge Opérationnelle-67462.0%-65800.0%-128156.5%-17774.8%-9493.4%-6796.9%-1659.9%-2454.5%
Marge EBITDA-48216.0%-61750.0%-119069.6%-16852.1%-9645.3%-6204.0%-1651.6%-2404.2%
Marge Nette-52252.0%-65383.3%-126747.8%-17624.8%-9867.9%-6407.4%-1690.3%-2344.6%
Marge FCF-43444.0%-54985.2%-115821.7%-15718.4%-8055.4%-5627.0%-1484.2%-1990.3%
Taux d'Imposition Effectif0.7%-0.0%0.3%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%0.1%

Données par Action (10 ans)

Année2017201820192020202120222023202420252026
FCF par Action$-20.12$-16.42$-19.26$-11.71$-8.90$-9.14$-5.05$-3.50$-3.13$-2.08
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$1.1M$1.3M$1.5M$2.3M$3.5M$4.0M$4.6M$5.2M$6.3M$9.7M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres203.55%
Rentabilité du capital investi-117.79%
Rentabilité des actifs-100.41%
Marge brute19.00%
Marge opérationnelle-2412.14%
Marge nette-2424.75%

Santé financière

Dette / Capitaux propres-1.81
Ratio de liquidité0.33
Piotroski F-Score3
Altman Z-Score-17.73

Ratios Clés (10 ans)

Année2017201820192020202120222023202420252026
PER-4.02-4.94-2.03-5.52-2.23-0.96-1.04-1.44-1.39-0.86
P/B3.704.533.342.871.951.322.20314.40-4.58-0.88
P/V0.002582.501347.826995.130.00169.21102.1892.5823.4820.04
Marge Brute0.0%96.0%96.3%-6726.1%0.0%-350.0%96.9%98.8%49.0%44.6%
Marge Opérationnelle0.0%-67462.0%-65800.0%-128156.5%0.0%-17774.8%-9493.4%-6796.9%-1659.9%-2454.5%
Marge Nette0.0%-52252.0%-65383.3%-126747.8%0.0%-17624.8%-9867.9%-6407.4%-1690.3%-2344.6%

Entreprises liées: ANTX · BOLD · IBIO · INTS · ITRM · JSPR · NXTC

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de PLUR: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions